Kheiron Medical Technologies, a London-based medtech startup which uses Machine Learning to help radiologists detect early signs of cancer has raised $22 million (€ 20 million) in a Series A funding round. The investment was led by European V.C. firm Atomico, with participation from Greycroft, Connect Ventures, Hoxton Ventures, and Exor Seeds.
The company is planning to use the funding to scale the clinical validation of Mia further by conducting a series of tests, confirming its effectiveness and safety and roll-outs in Europe, the United States, and Asia. As part of this investment, Atomico Principal Irina Haivas will join the board.